(Q40400390)

20 September 2017

1 reference

title

Surgical options in the treatment of hepatic metastasis from colorectal cancer (English)

1 reference

20 September 2017

1 reference

Blumgart LH

1

1 reference

20 September 2017

Fong Y

series ordinal

2

1 reference

20 September 2017

publication date

1 May 1995

1 reference

Current Problems in Surgery

20 September 2017

published in

1 reference

20 September 2017

volume

32

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

333-421

1 reference

The natural history of primary and secondary malignant tumors of the liver I.The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Pattern of recurrence in liver resection for colorectal secondaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Prognosis of carcinoma of the large bowel in the presence of liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Natural history of patients with untreated liver metastases from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Inhibiting IL-6 in human multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

5FU infusion with mitomycin-C versus 5FU infusion with methyl-CCNU in the treatment of advanced colon cancer.A southwest oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Surgical Treatment of Hepatic Metastases From Colorectal Cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Cancer of the colon and rectum; statistical study, with end-results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Survival of patients at pennsylvania hospital with hepatic metastases from carcinoma of the colon and rectum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Palliative operative management in rectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Metastatic disease in the liver from colorectal cancer: an appraisal of liver surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic resection for metastases from colorectal carcinoma is of dubious value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Resection of hepatic metastases from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

A new technique for hepatic infusional chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic resection for metastatic colon and rectal cancer. An evaluation of preoperative and postoperative factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Resection of synchronous liver metastases from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic resection of metastatic colorectal carcinoma: a ten-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Bacterial translocation after major hepatectomy in patients and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Results of extensive surgery for liver metastases in colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Retinoids and cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Major hepatic resection for metachronous metastases from colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Resection of hepatic and pulmonary metastases from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Apparent extra-hepatic invasion by metastatic tumours in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Effect of hepatic cryotherapy on serum CEA concentration in patients with multiple inoperable hepatic metastases from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Recurrence of colorectal cancer after hepatic resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Repeated hepatic resection for recurrent metastases from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Repeat liver resection for recurrent colorectal metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Repeat hepatic resections for metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

THE NATURAL HISTORY OF CARCINOMA OF THE COLON AND RECTUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Regional treatment of hepatic metastases and hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Nitrogen embolus as a complication of hepatic cryosurgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Cryotherapy for liver metastases: a new approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

A 5-Year Study of Cryosurgery in the Treatment of Liver Tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

New surgical treatments for recurrent colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Regional hepatic chemotherapy using an implantable drug infusion pump

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Regional chemotherapy of colorectal cancer metastatic to the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Cytotoxic perfusion for colorectal liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

The role of hepatic artery ligation and dearterialization with infusion chemotherapy in advanced malignancies in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic artery ligation for liver metastasis in colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Intermittent occlusion of the hepatic artery and infusion chemotherapy for carcinoma of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Surgical anatomy and anatomical surgery of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Subtotal hepatectomy: A new procedure based on the inferior right hepatic vein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Resectability of large focal liver lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Pathological changes in the liver and computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Bile duct obstruction: radiologic evaluation of level, cause, and tumor resectability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Intraoperative ultrasonographic study of the liver. Methods and anatomic results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Extended left hepatectomy: Technical aspects of an evolving procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Large hepatocellular cancers: hepatic resection or liver transplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Liver resection under total vascular isolation. Variations on a theme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Technique of hepatic vascular exclusion for extensive liver resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Venous bypass in clinical liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Experience with total vascular isolation of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Effect of haemodilution on transfusion requirements in liver resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Postoperative albumin infusion therapy based on colloid osmotic pressure. A prospectively randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Blood transfusions and prognosis in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Cryoprobe as a "handle" for resection of metastatic liver tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Role of staging laparoscopy in the treatment of hepatic malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Survival after liver resection for secondary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Transient hepatic dearterialization followed by regional intra-arterial 5-fluorouracil infusion as treatment for liver tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Repeat hepatectomy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Surgical therapy for recurrent liver metastases from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Resection of 'recurrent' colorectal metastases to the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

Newer anatomy of the liver and its variant blood supply and collateral circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980012-7

10.1016/S0011-3840(05)80012-7

7 January 2021

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fce4yesjabc2fmj3bdfede4sty

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_fce4yesjabc2fmj3bdfede4sty

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fce4yesjabc2fmj3bdfede4sty

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/fce4yesjabc2fmj3bdfede4sty

1 reference